The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 11.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (14 analysts) rates it hold, with a mean price target of $47.
Fortune Brands Innovations, Inc.
FBIN · the NYSE · USD · Market cap $4.7B · 10,000 employees
Fortune Brands Innovations, Inc.
FAIL · Does not pass the screenScreen close, 2026-09-21 · not a live quote
Screened 2026-09-21 · the tape above runs as of 11:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 39.60 against the desk's fair-value range, base estimate 42.09, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Fortune Brands Innovations, Inc. holds its Markdown at $39.60. Consolidating, no directional conviction, held for 19 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 19 days |
| Price at the screen | $39.60 |
| Valuation | 31.94 trailing · 11.47 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.37 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 42.77% | Below 33% | Interest-bearing debt is 42.8% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 11.92% | Below 49% | Money owed to the company is 11.9% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.15% | Below 5% | Only 0.1% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. A 6.3% margin of safety to the base estimate.
Third-party analyst targets: 15 covering, consensus None. The average target sits +39% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsHousing Products Firm Trades Above Fair Value
Picture a contractor ordering taps and locks for a new suburb just as mortgage rates climb and buyers vanish. Fortune Brands sits right in that slowdown, with revenue already shrinking 2% and margins stuck at 6%. Its shares sit at $51.45 while our fair value sits at $40.44, so the stock offers no margin of safety and the opportunity rating stays at none.
Forward earnings trade at 14.1 times, which looks modest until you remember building-products demand rises and falls with the housing cycle. Return on equity of just 12% shows limited pricing power, and the unknown moat leaves little protection when volumes drop. Analysts see a hold with a $50 median target, confirming the market already prices in muted prospects.
The real danger is the classic cyclical trap: a low multiple often signals peak earnings rather than a bargain. A further housing correction would hit both sales and cash flow hard, even though the business clears the ethical screen. Analysis, not advice.
| Forward P/E | 11.5xreasonably valued |
| Trailing P/E | 31.9xa premium valuation |
| EPS, trailing | 1.24 |
| EPS, forward | 3.45 |
| Revenue growth | -4.1%revenue is shrinking |
| Profit margin | 3.4%barely profitable |
| Return on equity | 6.4%a modest return on shareholder capital |
| FCF yield | 6.16% |
| Dividend yield | 241.00% |
| Debt to equity | 1.21a meaningful debt load worth watching |
| Current ratio | 2.01comfortably covers its short-term bills |
| Beta | 1.37moves a little more than the market |
| Short interest, float | 0.06% |
| 52-week range | 32.34 - 64.84 |
| Market cap | $4.7B |
| Employees | 10,000 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeFBIN trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 19.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (14 analysts) rates it hold, with a mean price target of $47.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (14 analysts) rates it hold, with a mean price target of $47.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Trane Or Allegion: Which One Is The Cheaper Way In? Trefis · 4d ago
- 3 Stocks Under $50 with Questionable Fundamentals StockStory · 5d ago
- 3 Value Stocks That Concern Us StockStory · 11d ago
- Strong Free Cash Flow and Margin Expansion Make Fortune Brands Innovations (FBIN) Attractive Insider Monkey · 13d ago
- This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock Picks Insider Monkey · 19d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $37.51 | +8.1% | $0.26 | $1,088 | +8.8% |
| 2 months | $40.08 | +1.2% | $0.26 | $1,018 | +1.8% |
| 3 months | $42.96 | -5.6% | $0.26 | $950 | -5.0% |
| 6 months | $51.81 | -21.8% | $0.52 | $793 | -20.7% |
| 1 year | $51.69 | -21.6% | $1.02 | $804 | -19.6% |
| 2 years | $63.82 | -36.5% | $2.00 | $667 | -33.3% |
| 3 years | $62.53 | -35.2% | $2.94 | $695 | -30.5% |
| 5 years | $77.96 | -48.0% | $4.80 | $582 | -41.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever FBIN does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.